A Randomized Study of Minimally Invasive Percutaneous Nephrolithotomy (MPCNL) with the aid of a patented suctioning sheath in the treatment of renal calculus complicated by pyonephrosis by one surgery
Tóm tắt
Calculus pyonephrosis is difficult to manage. The aim of this study is to explore the value of a patented suctioning sheath assisted minimally invasive percutaneous nephrolithotomy (MPCNL) in the treatment of calculus pyonephrosis. One hundred and eighty two patients with calculus pyonephrosis were randomizely divided into observation group (n = 91) and control group (n = 91). The control group was treated with MPCNL traditionally using peel-away sheath while the observation group was treated with MPCNL using the patented suctioning sheath. All the patients in the observation group underwent one stage surgical treatment, 14 patients in the control group underwent first-stage surgery with the rest of the group underwent one stage surgery. The complication rate was 12.1% in the observation group, significantly lower than the rate in the control group which was 51.6%; One surgery stone clearance in the observation group was 96.7% while it was 73.6% in the control group; operative time in the observation group was (54.5 ± 14.5) min, compared to (70.2 ± 11.7) min in the control group; the bleeding amount in the observation group was (126.4 ± 47.2) ml, compared to (321.6 ± 82.5) ml in the control group; the hospitalization duration for the observation group was (6.4 ± 2.3) days, compared to (10.6 ± 3.7) days in the control group. Comparison of the above indicators, the observation group was better than the control group with significant difference (p < 0.001 each). Minimally invasive percutaneous nephrolithotomy with the aid of the patented suctioning sheath in the treatment of calculus pyonephrosis in one surgery is economic, practical, and warrants clinical promotion. This study was registered with Chinese Clinical Trial Registry on May 18, 2016 (retrospective registration) with a trial registration number of
ChiCTR-IOR-16008490
.
Tài liệu tham khảo
Zeng G, Mai Z, Zhao Z, Li X, Zhong W, Yuan J, Wu K, Wu W. Treatment of upper urinary calculi with Chinese minimally invasive percutaneous nephrolithotomy: a single-center experience with 12,482 consecutive patients over 20 years. Urolithiasis. 2013;41(3):225–9.
Deng X, Song L, Xie D, Huang J, Zhu L, Wang X, Fan D, Peng Z, Hu M, Yang Z et al. Predicting Outcomes after Minimally Percutaneous Nephrolithotomy with the Aid of a Patented System by Using the Guy’s Stone Score. Urol Int. 2016;97:67–71.
Yang Z, Song L, Xie D, Hu M, Peng Z, Liu T, Du C, Zhong J, Qing W, Guo S. Comparative study of outcome in treating upper ureteral impacted stones using minimally invasive percutaneous nephrolithotomy with Aid of patented system or transurethral ureteroscopy. Urology. 2012;80(6):1192–7.
Song L, Chen Z, Liu T, Zhong J, Qin W, Guo S, Peng Z, Hu M, Du C, Zhu L. The application of a patented system to minimally invasive percutaneous nephrolithotomy. J Endourol. 2011;25(8):1281–6.
Erdil T, Bostanci Y, Ozden E, Atac F, Yakupoglu YK, Yilmaz AF, Sarikaya S. Risk factors for systemic inflammatory response syndrome following percutaneous nephrolithotomy. Urolithiasis. 2013;41(5):395–401.
Guohua Z, Wen Z, Xun L, Wenzhong C, Yongzhong H, Zhaohui H, Ming L, Kaijun W. The influence of minimally invasive percutaneous nephrolithotomy on renal pelvic pressure in vivo. Surg Laparosc Endosc Percutan Tech. 2007;17(4):307–10.
Hinman F, Redewill FH. Pyelovenous back flow. J Am Med Assoc. 1926;87(16):1287–93.
De La Rosette J, Denstedt J, Geavlete P, Keeley F, Matsuda T, Pearle M, Preminger G, Traxer O. The clinical research office of the endourological society ureteroscopy global study: indications, complications, and outcomes in 11,885 patients. J Endourol. 2014;28(2):131–9.
Zhong W, Zeng G, Wu K, Li X, Chen W, Yang H. Does a smaller tract in percutaneous nephrolithotomy contribute to high renal pelvic pressure and postoperative fever? J Endourol. 2008;22(9):2147–52.
Chen L, Li J, Huang X, Wang X. Analysis for risk factors of systemic inflammatory response syndrome after one-phase treatment for apyrexic calculous pyonephrosis by percutaneous nephrolithotomy. Beijing da xue xue bao Yi xue ban = J Peking Univ Health Sci. 2014;46(4):566–9.
Zhou DQ, Wang J, Li WG, Pang X, Liu SW, Yu XX, Jiang B. Treatment of calculous pyonephrosis with percutaneous nephrolithotomy via the standard access. Nan fang yi ke da xue xue bao = J South Med Univ. 2009;29(7):1417–9.
Wang J, Zhou DQ, He M, Li WG, Pang X, Yu XX, Jiang B. One-phase treatment for calculous pyonephrosis by percutaneous nephrolithotomy assisted by EMS LithoClast master. Chin Med J. 2013;126(8):1584–6.